Your browser doesn't support javascript.
loading
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis.
Smith, Harvey W; Hirukawa, Alison; Sanguin-Gendreau, Virginie; Nandi, Ipshita; Dufour, Catherine R; Zuo, Dongmei; Tandoc, Kristofferson; Leibovitch, Matthew; Singh, Salendra; Rennhack, Jonathan P; Swiatnicki, Matthew; Lavoie, Cynthia; Papavasiliou, Vasilios; Temps, Carolin; Carragher, Neil O; Unciti-Broceta, Asier; Savage, Paul; Basik, Mark; van Hoef, Vincent; Larsson, Ola; Cooper, Caroline L; Vargas Calderon, Ana Cristina; Beith, Jane; Millar, Ewan; Selinger, Christina; Giguère, Vincent; Park, Morag; Harris, Lyndsay N; Varadan, Vinay; Andrechek, Eran R; O'Toole, Sandra A; Topisirovic, Ivan; Muller, William J.
Afiliación
  • Smith HW; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Hirukawa A; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Sanguin-Gendreau V; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Nandi I; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Dufour CR; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Zuo D; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Tandoc K; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Leibovitch M; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Singh S; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Rennhack JP; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Swiatnicki M; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Lavoie C; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Papavasiliou V; Lady Davis Institute for Medical Research, McGill University, Montréal, QC, H3T 1E2, Canada.
  • Temps C; Lady Davis Institute for Medical Research, McGill University, Montréal, QC, H3T 1E2, Canada.
  • Carragher NO; Case Comprehensive Cancer Center, Case Western University, Cleveland, OH, 44145, USA.
  • Unciti-Broceta A; Department of Physiology, Michigan State University, East Lansing, MI, 48824, USA.
  • Savage P; Department of Physiology, Michigan State University, East Lansing, MI, 48824, USA.
  • Basik M; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • van Hoef V; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Larsson O; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Cooper CL; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Vargas Calderon AC; Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
  • Beith J; Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
  • Millar E; Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
  • Selinger C; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Giguère V; Department of Medicine, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Park M; Case Comprehensive Cancer Center, Case Western University, Cleveland, OH, 44145, USA.
  • Harris LN; Department of Medicine, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Varadan V; Department of Surgery, McGill University, Montréal, QC, H3A 1A3, Canada.
  • Andrechek ER; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Stockholm, 171 76, Sweden.
  • O'Toole SA; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Stockholm, 171 76, Sweden.
  • Topisirovic I; Department of Anatomical Pathology, Pathology Queensland, Princess Alexandra Hospital, Woolloongabba, QLD, 4102, Australia.
  • Muller WJ; PA Southside Clinical School, School of Medicine, University of Queensland, Brisbane, QLD, 4102, Australia.
Nat Commun ; 10(1): 2901, 2019 07 01.
Article en En | MEDLINE | ID: mdl-31263101
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Familia-src Quinasas / Epigénesis Genética / Complejo Represivo Polycomb 2 Límite: Adult / Animals / Female / Humans / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Familia-src Quinasas / Epigénesis Genética / Complejo Represivo Polycomb 2 Límite: Adult / Animals / Female / Humans / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido